KORU Medical Systems, Inc.KRMDNASDAQ
Loading
Year-over-year research & development expense growth
3Y CAGR
-36.9%/yr
Quarterly compound
Percentile
P72
Within normal range
vs 3Y Ago
0.3x
Contraction
Streak
1 qtr
Consecutive growthStable
| Period | Value |
|---|---|
| Q4 2025 | 22.68% |
| Q3 2025 | -21.90% |
| Q2 2025 | 7.19% |
| Q1 2025 | 0.04% |
| Q4 2024 | -27.36% |
| Q3 2024 | 35.23% |
| Q2 2024 | -23.14% |
| Q1 2024 | 14.61% |
| Q4 2023 | -0.44% |
| Q3 2023 | -19.00% |
| Q2 2023 | 2.03% |
| Q1 2023 | -4.70% |
| Q4 2022 | 90.45% |
| Q3 2022 | -33.87% |
| Q2 2022 | 13.53% |
| Q1 2022 | 20.89% |
| Q4 2021 | 18.74% |
| Q3 2021 | 106.79% |
| Q2 2021 | 14.85% |
| Q1 2021 | -4.34% |
| Q4 2020 | -9.81% |
| Q3 2020 | 30.93% |
| Q2 2020 | 16.47% |
| Q1 2020 | -11.72% |
| Q4 2019 | 70.34% |
| Q3 2019 | -4.47% |
| Q2 2019 | 74.81% |
| Q1 2019 | 26.83% |
| Q4 2018 | -36.66% |
| Q3 2018 | 429.66% |
| Q2 2018 | 143.33% |
| Q1 2018 | -60.44% |
| Q4 2017 | 67.61% |
| Q3 2017 | -40.21% |
| Q2 2017 | -53.99% |
| Q1 2017 | -8.71% |
| Q4 2016 | -12.62% |
| Q3 2016 | 19.44% |
| Q2 2016 | -10.54% |
| Q1 2016 | 22.84% |